Numerous studies suggest that Ozempic and other GLP-1 medications may help with a range of conditions such as kidney failure, sleep apnea, Alzheimer's, and more It seems like every day a new study emerges linking Ozempic and similar drugs to new health benefits
GLP-1 Market Share, By Indication, 2025 (%) The obesity and weight management segment held a 28% share of the market in 2025 and is expected to grow at the fastest CAGR of 18.6% during the projection period
In 2022, over 2.5 billion adults worldwide were overweight, with 890 million living with obesity, while childhood obesity affected 37 million children under five and 390 million aged 519
Only the frequency and individual injection volume change
Compounded products typically have shorter shelf lives than FDA-approved versions
I'm excited to share a new publication in JAMA Psychiatry, which I had the privilege of leading